Oxilofrine hydrochloride | CAS# 942-51-8 (HCl) | sympathomimetic

MedKoo Cat#: 417371 | Name: Oxilofrine hydrochloride

Featured

Description:

WARNING: This product is for research use only, not for human or veterinary use.

Oxilofrine hydrochloride is the salt form of Oxilofrine, a sympathomimetic used to treat hypotensive states, with cardiac stimulatory effects similar to those of ephedrine. It has never been approved for use in the USA as a prescription drug or as a dietary supplement. Oxilofrine has been found to act predominantly as a beta1 agonist increasing the speed and force of heart muscle contraction (inotropic effects), specifically, increasing left ventricular ejection fraction and stroke volume; to increase blood pressure; to have variable effects on heart rate; and to potentially increase oxygen uptake by the lungs.

Chemical Structure

Oxilofrine hydrochloride

CAS#942-51-8 (HCl)

Theoretical Analysis

MedKoo Cat#: 417371

Name: Oxilofrine hydrochloride

CAS#: 942-51-8 (HCl)

Chemical Formula: C10H16ClNO2

Exact Mass: 0.0000

Molecular Weight: 217.69

Elemental Analysis: C, 55.17; H, 7.41; Cl, 16.28; N, 6.43; O, 14.70

Price and Availability

Size	Price	Availability	Quantity
10mg	USD 550.00	2 Weeks
100mg	USD 1,825.00	2 Weeks

Bulk Inquiry

Buy Now

Add to Cart

Related CAS #

942-51-8 (HCl) 365-26-4 (free base)

Synonym

Oxilofrine hydrochloride; Diben; Carnigen; EINECS 213-392-5

IUPAC/Chemical Name

(R*,S*)-4-Hydroxy-alpha-(1-(methylamino)ethyl)benzyl alcohol hydrochloride

InChi Key

ICBZSKCTKKUQSY-YUWZRIFDSA-N

InChi Code

InChI=1S/C10H15NO2.ClH/c1-7(11-2)10(13)8-3-5-9(12)6-4-8;/h3-7,10-13H,1-2H3;1H/t7-,10-;/m0./s1

SMILES Code

C[C@@H]([C@H](O)C1=CC=C(O)C=C1)NC.[H]Cl

Appearance

Solid powder

Purity

>98% (or refer to the Certificate of Analysis)

Shipping Condition

Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition

Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility

Soluble in DMSO

Shelf Life

>3 years if stored properly

Drug Formulation

This drug may be formulated in DMSO

Stock Solution Storage

0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code

2934.99.9001

More Info

Product Data

Product Data

Instruction

View handling instruction

Biological target:

Oxilofrine hydrochloride is the salt form of Oxilofrine, a sympathomimetic used to treat hypotensive states, with cardiac stimulatory effects similar to those of ephedrine.

In vitro activity:

TBD

In vivo activity:

TBD

Preparing Stock Solutions

The following data is based on the product molecular weight 217.69 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Concentration / Solvent Volume / Mass	1 mg	5 mg	10 mg
1 mM	1.15 mL	5.76 mL	11.51 mL
5 mM	0.23 mL	1.15 mL	2.3 mL
10 mM	0.12 mL	0.58 mL	1.15 mL
50 mM	0.02 mL	0.12 mL	0.23 mL

Formulation protocol:

TBD

In vitro protocol:

TBD

In vivo protocol:

TBD

1: Duiven E, van Loon LJC, Spruijt L, Koert W, de Hon OM. Undeclared Doping Substances are Highly Prevalent in Commercial Sports Nutrition Supplements. J Sports Sci Med. 2021 Mar 22;20(2):328-338. doi: 10.52082/jssm.2021.328. PMID: 34211326; PMCID: PMC8219275. 2: Cohen PA, Travis JC, Vanhee C, Ohana D, Venhuis BJ. Nine prohibited stimulants found in sports and weight loss supplements: deterenol, phenpromethamine (Vonedrine), oxilofrine, octodrine, beta-methylphenylethylamine (BMPEA), 1,3-dimethylamylamine (1,3-DMAA), 1,4-dimethylamylamine (1,4-DMAA), 1,3-dimethylbutylamine (1,3-DMBA) and higenamine. Clin Toxicol (Phila). 2021 Nov;59(11):975-981. doi: 10.1080/15563650.2021.1894333. Epub 2021 Mar 23. Erratum in: Clin Toxicol (Phila). 2022 Jun;60(6):671. doi: 10.1080/15563650.2022.2027083. PMID: 33755516. 3: Zhao J, Wang M, Avula B, Khan IA. Detection and quantification of phenethylamines in sports dietary supplements by NMR approach. J Pharm Biomed Anal. 2018 Mar 20;151:347-355. doi: 10.1016/j.jpba.2018.01.025. Epub 2018 Jan 31. PMID: 29413984. 4: Vevelstad M, Øiestad EL, Nerem E, Arnestad M, Bogen IL. Studies on Para- Methoxymethamphetamine (PMMA) Metabolite Pattern and Influence of CYP2D6 Genetics in Human Liver Microsomes and Authentic Samples from Fatal PMMA Intoxications. Drug Metab Dispos. 2017 Dec;45(12):1326-1335. doi: 10.1124/dmd.117.077263. Epub 2017 Oct 4. PMID: 28978661. 5: Xu J, Yan R. Determination of the Metabolite of Ephedrine, 4-Hydroxyephedrine, by LC-MS-MS in Rat Urine and Its Application in Excretion Profiles After Oral Administration of Ephedra sinica Stapf and Processing Ephedra sinica Stapf. J Chromatogr Sci. 2017 Feb;55(2):162-165. doi: 10.1093/chromsci/bmw165. Epub 2016 Oct 12. PMID: 27733484. 6: Cohen PA, Avula B, Venhuis B, Travis JC, Wang YH, Khan IA. Pharmaceutical doses of the banned stimulant oxilofrine found in dietary supplements sold in the USA. Drug Test Anal. 2017 Jan;9(1):135-142. doi: 10.1002/dta.1976. Epub 2016 Apr 7. PMID: 27062112. 7: Kim NH, Pham NB, Quinn RJ, Shim JS, Cho H, Cho SM, Park SW, Kim JH, Seok SH, Oh JW, Kwon HJ. The Small Molecule R-(-)-β-O-Methylsynephrine Binds to Nucleoporin 153 kDa and Inhibits Angiogenesis. Int J Biol Sci. 2015 Jul 16;11(9):1088-99. doi: 10.7150/ijbs.10603. PMID: 26221075; PMCID: PMC4515819. 8: Kong N, Yi R, Zhao S, Sandhu J, Lam G, Loganathan D, Morrissey B. Development and validation of a hydrophilic interaction liquid chromatography with tandem mass spectrometry method for the simultaneous detection and quantification of etilefrine and oxilofrine in equine blood plasma and urine. J Sep Sci. 2014 Nov;37(21):3015-23. doi: 10.1002/jssc.201400662. Epub 2014 Sep 30. PMID: 25143252. 9: Venhuis B, Keizers P, van Riel A, de Kaste D. A cocktail of synthetic stimulants found in a dietary supplement associated with serious adverse events. Drug Test Anal. 2014 Jun;6(6):578-81. doi: 10.1002/dta.1664. Epub 2014 May 6. PMID: 24802503. 10: Logan IC, Witham MD. Efficacy of treatments for orthostatic hypotension: a systematic review. Age Ageing. 2012 Sep;41(5):587-94. doi: 10.1093/ageing/afs061. Epub 2012 May 16. PMID: 22591985. 11: Kim NH, Pham NB, Quinn RJ, Kwon HJ. R-(-)-beta-O-methylsynephrine, a natural product, inhibits VEGF-induced angiogenesis in vitro and in vivo. Biochem Biophys Res Commun. 2010 Aug 13;399(1):20-3. doi: 10.1016/j.bbrc.2010.07.025. Epub 2010 Jul 17. PMID: 20643105. 12: Hempel B, Kroll M, Schneider B. Wirksamkeit und Verträglichkeit eines pflanzlichen Arzneimittels mit Weissdornbeeren und D-Campher bei hypotonen und orthostatischen Kreislaufregulationsstörungen. Ergebnisse einer retrospektiven epidemiologischen Kohortenstudie [Efficacy and safety of a herbal drug containing hawthorn berries and D-camphor in hypotension and orthostatic circulatory disorders/results of a retrospective epidemiologic cohort study]. Arzneimittelforschung. 2005;55(8):443-50. German. doi: 10.1055/s-0031-1296886. PMID: 16149711. 13: Staack RF, Fehn J, Maurer HH. New designer drug p-methoxymethamphetamine: studies on its metabolism and toxicological detection in urine using gas chromatography-mass spectrometry. J Chromatogr B Analyt Technol Biomed Life Sci. 2003 Jun 5;789(1):27-41. doi: 10.1016/s1570-0232(02)01018-8. PMID: 12726841. 14: Schmid MG, Laffranchini M, Dreveny D, Gübitz G. Chiral separation of sympathomimetics by ligand exchange capillary electrophoresis. Electrophoresis. 1999 Sep;20(12):2458-61. doi: 10.1002/(SICI)1522-2683(19990801)20:12<2458::AID- ELPS2458>3.0.CO;2-8. PMID: 10499338. 15: Romanenko VG, Gebara R, Miller KM, Njus D. Determination of transport parameters of permeant substrates of the vesicular amine transporter. Anal Biochem. 1998 Mar 15;257(2):127-33. doi: 10.1006/abio.1997.2546. PMID: 9514783. 16: Grobecker HF, Kees F. Pharmacokinetic parameters and haemodynamic actions of midodrine in young volunteers. Int Angiol. 1993 Jun;12(2):119-24. PMID: 7690382. 17: Dominiak P, Kees F, Welzel D, Grobecker H. Cardiovascular parameters and catecholamines in volunteers during passive orthostasis. Influence of antihypotensive drugs. Arzneimittelforschung. 1992 May;42(5):637-42. PMID: 1530677. 18: Pohl K, Kriech W. Therapie orthostatischer Kreislaufregulationsstörungen. Plazebo-kontrollierte Doppelblindstudie mit Oxilofrin [Therapy of orthostatic disorders of cardiovascular regulation. Placebo controlled double-blind study with oxilofrine]. Fortschr Med. 1991 Nov 20;109(33):685-8. German. PMID: 1769643. 19: Schwaiger M, Kalff V, Rosenspire K, Haka MS, Molina E, Hutchins GD, Deeb M, Wolfe E Jr, Wieland DM. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation. 1990 Aug;82(2):457-64. doi: 10.1161/01.cir.82.2.457. PMID: 2372893. 20: Kauert G, Herrle I, Schoppek B. Detection of oxilofrine in plasma and urine by high-performance liquid chromatography with electrochemical detection and comparison with gas chromatography-mass spectrometry. J Chromatogr. 1988 Jul 15;428(2):291-300. doi: 10.1016/s0378-4347(00)83920-1. PMID: 3215932.